GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Umedic Group Bhd (XKLS:0256) » Definitions » EV-to-EBITDA

Umedic Group Bhd (XKLS:0256) EV-to-EBITDA : 10.43 (As of May. 22, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Umedic Group Bhd EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Umedic Group Bhd's enterprise value is RM142.53 Mil. Umedic Group Bhd's EBITDA for the trailing twelve months (TTM) ended in Jan. 2025 was RM13.67 Mil. Therefore, Umedic Group Bhd's EV-to-EBITDA for today is 10.43.

The historical rank and industry rank for Umedic Group Bhd's EV-to-EBITDA or its related term are showing as below:

XKLS:0256' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.79   Med: 14.07   Max: 15.52
Current: 10.43

During the past 6 years, the highest EV-to-EBITDA of Umedic Group Bhd was 15.52. The lowest was 9.79. And the median was 14.07.

XKLS:0256's EV-to-EBITDA is ranked better than
66.73% of 493 companies
in the Medical Devices & Instruments industry
Industry Median: 15.45 vs XKLS:0256: 10.43

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-22), Umedic Group Bhd's stock price is RM0.42. Umedic Group Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 was RM0.022. Therefore, Umedic Group Bhd's PE Ratio (TTM) for today is 19.09.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Umedic Group Bhd EV-to-EBITDA Historical Data

The historical data trend for Umedic Group Bhd's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Umedic Group Bhd EV-to-EBITDA Chart

Umedic Group Bhd Annual Data
Trend Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
EV-to-EBITDA
Get a 7-Day Free Trial - - - - -

Umedic Group Bhd Quarterly Data
Jul19 Jul20 Jul21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 13.41 15.08

Competitive Comparison of Umedic Group Bhd's EV-to-EBITDA

For the Medical Devices subindustry, Umedic Group Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Umedic Group Bhd's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Umedic Group Bhd's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Umedic Group Bhd's EV-to-EBITDA falls into.


;
;

Umedic Group Bhd EV-to-EBITDA Calculation

Umedic Group Bhd's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=142.530/13.666
=10.43

Umedic Group Bhd's current Enterprise Value is RM142.53 Mil.
Umedic Group Bhd's EBITDA for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM13.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Umedic Group Bhd  (XKLS:0256) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Umedic Group Bhd's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.42/0.022
=19.09

Umedic Group Bhd's share price for today is RM0.42.
Umedic Group Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.022.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Umedic Group Bhd EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Umedic Group Bhd's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Umedic Group Bhd Business Description

Traded in Other Exchanges
N/A
Address
PMT 790, Jalan Cassia Selatan 5/2, Taman Perindustrian Batu Kawan, Pulau Pinang, Bandar Cassia, PNG, MYS, 14110
Umedic Group Bhd is principally involved in the marketing and distribution of various branded medical devices and consumables as well as the provision of after-sales service for all products. The company is also involved in developing, manufacturing, and marketing of medical consumables. It has two reportable segments: marketing and distribution, which includes marketing and distribution of medical devices and the provision of after-sales service; the manufacturing segment includes developing, manufacturing, and marketing of medical devices. The company generates the majority of its revenue from the marketing and distribution segment. The company has customers in Asia Pacific, Americas, Europe, Middle East, Africa, and Oceania geographically.

Umedic Group Bhd Headlines

No Headlines